Looks like there`s been an error while trying to load this page.
Our team has been notified but please contact us using the email support widget if the problem persists.
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM Pb Multiple | 1.6x - 1.8x | 1.7x |
| Historical Pb Multiple | 1.3x - 3.0x | 1.9x |
| Fair Value | ¥4.63 - ¥5.12 | ¥4.88 |
| Upside | 16.4% - 28.6% | 22.5% |
| Benchmarks | - | Full Ticker |
| Beijing Tongrentang Co., Ltd | 60,008,500.0% | SHSE:600085 |
| Kangmei Pharmaceutical Co., Ltd. | 60,051,800.0% | SHSE:600518 |
| Xiangxue Pharmaceutical Co.,Ltd. | 30,014,700.0% | SZSE:300147 |
| China Traditional Chinese Medicine Holdings Co. Limited | 57,000.0% | SEHK:570 |
| Shanghai Hile Bio-Technology Co., Ltd. | 60,371,800.0% | SHSE:603718 |
| Tianjin Chase Sun Pharmaceutical Co.,Ltd | 30,002,600.0% | SZSE:300026 |
| Select Price / Book Ratio | ||||||||
| Benchmark Companies | ||||||||
| 600085 | 600518 | 300147 | 570 | 603718 | 300026 | |||
| SHSE:600085 | SHSE:600518 | SZSE:300147 | SEHK:570 | SHSE:603718 | SZSE:300026 | |||
| Historical Net Income Growth | ||||||||
| 5Y CAGR | 9.1% | NM- | NM- | -49.1% | 69.7% | -44.4% | ||
| 3Y CAGR | 7.5% | -89.7% | NM- | -69.6% | 47.0% | -68.5% | ||
| Latest Twelve Months | -11.0% | -94.0% | -112.2% | -95.8% | 313.7% | -93.9% | ||
| Historical Net Income Profit Margin | ||||||||
| 5 Year Average Margin | 13.3% | -102.3% | -18.0% | 8.4% | 18.9% | 7.2% | ||
| Prior Fiscal Year | 9.3% | 2.1% | -16.9% | 7.1% | 26.1% | 8.3% | ||
| Latest Fiscal Year | 8.2% | 0.2% | -46.2% | 0.3% | 63.2% | 0.4% | ||
| Latest Twelve Months | 8.2% | 0.2% | -53.2% | 0.3% | 70.8% | 0.4% | ||
| Return on Equity | ||||||||
| 5 Year Average Margin | 12.2% | -47.6% | -18.4% | 6.7% | 5.9% | 6.3% | ||
| Prior Fiscal Year | 13.4% | 1.5% | -18.4% | 6.2% | 5.3% | 6.0% | ||
| Latest Twelve Months | 11.2% | 0.1% | -63.8% | 0.3% | 13.3% | 0.3% | ||
| Next Fiscal Year | 12.6% | #NUM! | #NUM! | 3.5% | 8.4% | 1.2% | ||
| Two Fiscal Years Forward | 13.4% | 0.1% | -147.5% | 4.2% | 8.1% | 1.4% | ||
| Current Trading Multiples | ||||||||
| Price / LTM Sales | 2.6x | 5.4x | 3.4x | 0.6x | 19.2x | 2.1x | ||
| Price / LTM EPS | 31.8x | 2993.7x | -6.4x | 189.0x | 27.1x | 506.3x | ||
| Price / Book | 3.5x | 4.0x | 6.1x | 0.5x | 3.2x | 1.4x | ||
| Price / Fwd Book | 3.6x | 4.0x | 5.4x | 0.5x | 3.0x | 1.4x | ||
| Low | Mid | High | ||||||
| Benchmark P/B Ratio | 0.5x | 3.5x | 6.1x | |||||
| Historical P/B Ratio | 1.3x | 1.9x | 3.0x | |||||
| Selected P/B Multiple | 1.6x | 1.7x | 1.8x | |||||
| (x) Book Value | 8,704 | 8,704 | 8,704 | |||||
| Equity Value | |||||||
| Benchmark Companies | |||||||
| (in millions) | 600085 | 600518 | 300147 | 570 | 603718 | 300026 | |
| Value of Common Equity | 48,961 | 28,488 | 5,522 | 10,438 | 5,003 | 11,957 | |
| (/) Shares Outstanding | 1,371.5 | 13,828.9 | 661.3 | 5,035.8 | 655.7 | 3,004.2 | |
| Implied Stock Price | 35.70 | 2.06 | 8.35 | 2.07 | 7.63 | 3.98 | |
| FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.00 | 0.91 | 1.00 | 1.00 | |
| Implied Stock Price (Trading Cur) | 35.70 | 2.06 | 8.35 | 2.27 | 7.63 | 3.98 | |
| Trading Currency | CNY | CNY | CNY | HKD | CNY | CNY | |
| FX Rate to Reporting Currency | 1.00 | 1.00 | 1.00 | 0.91 | 1.00 | 1.00 | |